We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

152 hedge funds and large institutions have $137M invested in SANGAMO THERAPEUTICS INC in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 43

4.95% less ownership

Funds ownership: 66.6% → 61.65% (-5%)

15% less funds holding

Funds holding: 179 → 152 (-27)

30% less capital invested

Capital invested by funds: $198M → $137M (-$60.1M)

48% less call options, than puts

Call options by funds: $85K | Put options by funds: $162K

56% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 48

Holders
152
Holders Change
-27
Holders Change %
-15.08%
% of All Funds
2.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
47
Reduced
43
Closed
48
Calls
$85K
Puts
$162K
Net Calls
-$77K
Net Calls Change
-$215K

Top Buyers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
+$4.66M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$3.22M
3
Citadel Advisors
Citadel Advisors
Florida
+$1.72M
4
ECM
ExodusPoint Capital Management
New York
+$1.06M
5
GC
Globeflex Capital
California
+$953K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$8.61M
2
APM
Avidity Partners Management
Texas
-$4.35M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$2.71M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$2.41M
5
Rafferty Asset Management
Rafferty Asset Management
New York
-$1.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
TWM
126
Tradition Wealth Management
Minnesota
$7K – – –
VCM
127
Vigilant Capital Management
Maine
$7K – – –
US Bancorp
128
US Bancorp
Minnesota
$6.5K -$8.35K -6,113 -55%
FCMT
129
Founders Capital Management (Texas)
Texas
$5.2K – – –
TWC
130
TD Waterhouse Canada
Ontario, Canada
$3.29K – – –
CUAMC
131
China Universal Asset Management Company
China
$2.93K -$42 -31 -1%
AF
132
Advisornet Financial
Minnesota
$2.71K – – –
AF
133
Allworth Financial
California
$1.3K – – –
HWM
134
HighMark Wealth Management
Minnesota
$1.3K – – –
SPIA
135
Steward Partners Investment Advisory
New York
$1.3K – – –
BFEC
136
Benjamin F. Edwards & Company
Missouri
$1K – – –
Daiwa Securities Group
137
Daiwa Securities Group
Japan
$1K – – –
PNC Financial Services Group
138
PNC Financial Services Group
Pennsylvania
$753 -$585 -428 -43%
VWM
139
Venturi Wealth Management
Texas
$650 – – –
GRP
140
Global Retirement Partners
California
$637 – – –
WIM
141
WealthPlan Investment Management
Nebraska
$520 – – –
FFA
142
Farther Finance Advisors
California
$520 +$547 +400 New
Northwestern Mutual Wealth Management
143
Northwestern Mutual Wealth Management
Wisconsin
$501 +$526 +385 New
WT
144
Whittier Trust
California
$491 – – –
GWMI
145
Guardian Wealth Management (Illinois)
Illinois
$299 – – –
AFG
146
Albion Financial Group
Utah
$260 – – –
BWM
147
Baystate Wealth Management
Massachusetts
$260 – – –
National Bank of Canada
148
National Bank of Canada
Quebec, Canada
$260 – – –
UB
149
UMB Bank
Missouri
$260 – – –
CAS
150
Coppell Advisory Solutions
Texas
$250 +$273 +200 New
4 5
6
7 8

SGMO Hedge Fund Activity: Q2 2023 in Review

152 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2023, worth a combined $137M — down 30% from $198M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of SGMO and 21 opened new positions — a net loss of 27 holders — while 43 trimmed existing stakes and 47 added.

The largest buyer was Wasatch Advisors, adding an estimated $4.66M. The largest seller was State Street, cutting an estimated $8.61M.

  • 152 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2023, down from 179 in Q1 2023.
  • Funds reported $137M of SANGAMO THERAPEUTICS INC stock for Q2 2023, down 30% quarter-over-quarter.
  • 21 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2023 and 48 closed out, a net change of -27 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2023 was Wasatch Advisors, an estimated $4.66M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2023 was State Street, an estimated $8.61M sold.

Based on aggregated 13F filings for Q2 2023.